The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy

NCT01213498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Nephropathy
Cardiovascular Diseases

Interventions

DRUG: Atorvastatin
DRUG: Unikalk

Sponsor

Erling Bjerregaard Pedersen